MARKET

PSTV

PSTV

Plus Therapeutics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.430
-0.160
-10.06%
After Hours: 1.450 +0.02 +1.40% 17:21 04/03 EDT
OPEN
1.560
PREV CLOSE
1.590
HIGH
1.580
LOW
1.400
VOLUME
115.17K
TURNOVER
--
52 WEEK HIGH
22.89
52 WEEK LOW
0.9310
MARKET CAP
5.55M
P/E (TTM)
-0.1326
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PSTV stock price target is 5.00 with a high estimate of 5.00 and a low estimate of 5.00.

EPS

PSTV News

More
  • Plus Therapeutics Announces Dr. Gregory Stein as Head of Clinical Development
  • GlobeNewswire · 3d ago
  • Mid-Morning Market Update: Markets Rise; McCormick Posts Mixed Q1 Results
  • Benzinga · 4d ago
  • Plus Therapeutics FY19 EPS $(8.27) Up From $(86.98) YoY, Sales $6.998M Up From $2.983M YoY
  • Benzinga · 4d ago
  • Plus Therapeutics Reports Fourth Quarter and Full Fiscal Year 2019 Financial and Business Results
  • GlobeNewswire · 4d ago

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About PSTV

Plus Therapeutics, Inc., formerly Cytori Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers. The Company is focused on developing generic oncology drugs that address unmet medical and market needs. The Company’s lead product candidate, DocePLUS, is an albumin-stabilized PEGylated liposomal formulation of docetaxel. DocePLUS is developed for the treatment of patients with small cell lung cancer (SCLC). The Company is also developing DoxoPLUS, which is a generic PEGylated liposomal formulation of doxorubicin. DoxoPLUS is developed for the treatment of breast cancer, ovarian cancer, multiple myeloma and Kaposi’s sarcoma.
More

Webull offers kinds of Plus Therapeutics Inc stock information, including NASDAQ:PSTV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSTV stock news, and many more online research tools to help you make informed decisions.